Clinical outcomes of post-remission therapy using (90)yttrium ibritumomab tiuxetan (Zevalin®) for high-risk patients with diffuse large B-cell lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 19 February 2011 |
| Author/s |
author: Seok-Goo Cho |
| Publication date | February 19, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |